The controversial subject of furosemide, the anti-bleeder medication widely used in North American racing, will be the subject of the next "Talkin' Horses with The Blood-Horse" live podcast at 2 p.m. EDT, Tuesday, June 26.
- By Tom LaMarra
The Thoroughbred Racing Associations has endorsed a policy for medication reform that has been supported by many industry stakeholders but so far acted upon piecemeal in various jurisdictions.
Some foreign racing organizations issued statements June 14 backing action by the Kentucky Horse Racing Commission to phase out use of race-day furosemide in graded and listed stakes over three years beginning Jan. 1, 2014.
The Kentucky Horse Racing Commission, by a 7-5 vote with one abstention June 13, approved an administrative regulation that would ban the use of furosemide on race day in graded and listed stakes over a three-year period.
In a development that figures to play out in other racing states, two New York senators said June 12 the anti-bleeding medication furosemide should not be banned on race day.
In advance of an expected vote by the Kentucky Horse Racing Commission June 13, the American Graded Stakes Committee reaffirmed its desire to ban all race-day medication in graded stakes for 2-year-olds.
During an oddly lopsided meeting on a proposal to phase-out use of furosemide on race day in listed and graded stakes in Kentucky, proponents of the therapeutic anti-bleeding medication made their case. But it may not matter.
A new law that allows for an expansion of racetrack card clubs in Minnesota also permits the Minnesota Racing Commission to set threshold testing levels for therapeutic medications used in racehorses.
The Kentucky Horse Racing Commission has scheduled a town hall meeting for June 5 to discuss the proposed three-year phase-out of the race-day drug furosemide.
There doesn't seem to be any middle ground in the debate over the anti-bleeding drug furosemide, and it seems doubtful the two sides will come together any time soon.
The Kentucky Horse Racing Commission May 16 kept alive a proposed regulation to phase out over three years race-day furosemide for graded and listed stakes, but not before the Equine Drug Research Council voted to reject it.
The Jockey Club May 15 released an eight-page letter it submitted to the New York State Racing and Wagering Board the previous day in regard to use of the race-day medication and furosemide and other related issues.
The Thoroughbred Owners and Breeders Association is the latest organization to respond to the New York State Racing and Wagering Board with its opinions on the use of the anti-bleeding medication furosemide on race day.
The Kentucky Horse Racing Commission confirmed it will discuss but not take final action May 16 on a proposal for the three-year phase-out of race-day furosemide in graded and listed stakes.
Darby Dan Farms owner John Phillips has been appointed to the Kentucky Horse Racing Commission as a replacement for John Ward Jr., who recently was hired as executive director of the regulatory agency.
The racing industry is closer to uniformity in drug regulations and penalties than many admit, but agreement on race-day anti-bleeding drugs in a "toxic" environment will require some heavy lifting, officials said May 2.
New York State Racing and Wagering Board chairman John Sabini says it's time for a fresh look at the state's race-day medication policy.
Members of Congress April 30 heard of problems in the Thoroughbred racing industry--most of them related to equine medication--but stopped short of a full endorsement of federal intervention.
Thoroughbred racing got further bruises April 30 during an allegation-ridden congressional hearing into equine health and medication issues that furthered a call for federal intervention--at least on some level.
Owners have clean, quick solution to Salix: Stop giving it to your racehorses read blog
An effort to make Kentucky the first state to ban the anti-bleeder medication furosemide for racing purposes failed April 16 when the state's Horse Racing Commission voted 7-7 not to approve it.
The Kentucky Horsemen's Benevolent and Protective Association has requested Gov. Steve Beshear not to sign any request to implement on an emergency basis a ban on race-day use of furosemide.
During April 10 meeting in Lexington, TOBA board of trustee members discussed other ways owners can be involved in ending race-day medication use.
- By Tom LaMarra
The Jockey Club officially released its "Reformed Racing Medication Rules" March 30, but broad adoption of the policies hinges on action by regulators in all racing jurisdictions.
Members of the National Thoroughbred Racing Association Safety and Integrity Alliance have been given the updated code of standards for 2012, officials said March 12.
The American Graded Stakes Committee is taking a more realistic approach to implementing a pilot program to ban race-day medication for juvenile graded stakes. It acknowledges regulatory change will take time.
Breeders' Cup Ltd. has reaffirmed its plan to ban race-day medications in World Championships races for 2-year-olds this year, despite recent action by the American Graded Stakes Committee to delay a similar ban.
Delaware Park was awarded 100 days of live Thoroughbred racing for 2012, but the track has no contract with the Delaware Thoroughbred Horsemen's Association for the meet.
Lenny and Steve review the Eclipse Award ceremony and the winners, Lasix, and more. Sponsored by Darby Dan Farm Watch Video
Panelists gathered for a Jan. 14 National Horsemen's Benevolent and Protective Association forum said there is no scientific evidence supporting a ban on the use of furosemide on race day.
A horse trained by Rick Dutrow Jr. has been disqualified from a stakes victory at Laurel Park because he was administrated Salix within two hours of the race, a violation of Maryland racing rules.
The National Horsemen's Benevolent and Protective Association will tackle several issues, including governmental affairs, high volume pari-mutuel bettors, and use of furosemide on race day during its convention Jan. 12-16.
The Association of Racing Commissioners International Model Rules Committee has adopted protocol that prohibits private veterinarians from administering furosemide on race day.
If testimony taken Nov. 14 in Kentucky, a major breeding and racing state, is any indication, the battle over use of furosemide on race day doesn't figure to end any time soon.
The pros and cons of race-day medication in racehorses were debated Nov. 14 during a lengthy meeting of the Kentucky Horse Racing Commission Race Day Medication Committee at the state Capitol.
A Kentucky Horse Racing Commission committee will hold what could be a six- to seven-hour meeting on race-day medication Nov. 14 in Frankfort, the state capital.
The Racing Medication and Testing Consortium (RMTC) board of directors heard important updates from the organization's race day medication, drug testing initiative (DTI), and research committees during a meeting Oct. 6.
A New York lawmaker said Sept. 13 he will introduce legislation banning use of "performance-enhancing drugs" such as the anti-bleeding medication furosemide, or Salix.
- By Tom LaMarra
Racing industry officials said a report that shows 99.5% of biological samples taken from racehorses and tested by laboratories in 2010 were "clean" dispels claims that horse racing is drug-ridden.
- By Tom LaMarra
Horsemen's groups largely support proposed changes in race-day medication rules but are drawing a line in the sand when it comes to the anti-bleeding drug Salix.
Lenny and Kenny Rice of NBC Sports review breaking news, the Saratoga race meet, Del Mar Exes race, Race Medication and Leftylenythelegend. Watch Video
- By Tom LaMarra
The Jockey Club has reiterated its calls for a phased-in ban on the anti-bleeding medication Salix but made clear Aug. 14 it wants "medication-free" horse racing.
- By Tom LaMarra
The American Graded Stakes Committee said Aug. 10 it will employ a pilot program that will ban race-day medications -- primarily the anti-bleeding drug Salix -- in graded 2-year-old stakes in 2012.
An industry consortium supports administration of Salix by regulatory veterinarians only and a ban on adjunct bleeder drugs, but will continue to study a pilot program proposal to ban the use of race-day Salix in 2-year-olds.
Two panels of the Kentucky Horse Racing Commission have begun the lengthy--and potentially contentious--process of reviewing and revising the state's medication regulations.
Gulfstream Park has not set a timetable for possible future contact with Florida racing regulators on chairman Frank Stronach's goal of phasing out use of legal race-day medications such as the anti-bleeding drug Salix.
Let's put all U.S. racing on par with the rest of the world. read blog
An Association of Racing Commissioners International committee will meet July 26 to hear opinions and testimony on use of race-day medication in racehorses.
A baby step toward progress was how organizers described the two-day International Race Day Medication Summit held June 13-14 at Belmont Park.
A South African study showed a strong heritability between some stallions and exercise-induced pulmonary hemorrhaging, also known as bleeding.
Most Popular Stories
- American Pharoah 'Just Cruising' in Workout
- Optimism High for Fasig-Tipton July Yearlings
- White Filly Beautiful Devil Carries Tradition
- Espinoza Tied in World's Best Jock Standings
- Horse Greeley Sold to Stand in Argentina
- Speedy Grade III Winner Chitu Retired
- Two 'Super Saturdays' for Belmont Fall Meet
- Kentucky Horsewoman Graves Dies at 61
- Keeneland Alters September Sale Format
- New York Coupled Entry Rules Modified